Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.660
0.00 (0.00%)
At close: Aug 7, 2026, 4:00 PM EDT
1.650
-0.010 (-0.60%)
After-hours: Aug 7, 2026, 4:10 PM EDT
Pulmatrix Earnings Call Transcripts
Fiscal Year 2024
-
Pulmatrix and Cullgen will merge, with Cullgen stockholders owning 96.4% of the combined entity, which will operate under the Cullgen name and focus on targeted protein degraders and DACs. The merger, expected to close by March 2025, brings $65M in cash and a robust clinical pipeline.